Before you sell to, join or invest in Aspira Women's Health Inc.
MentionFox check on Aspira Women's Health Inc.: no red flags found in 3 sources (checked 4 November 2026). mentionfox.com/c/funding/aspira-women-s-health-inc-form-d-25000002
Check Aspira Women's Health Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Aspira Women's Health Inc.?
Based on the records MentionFox holds for this company. No flag is not a clearance.
Aspira Women's Health Inc. filed a Form D with the Securities and Exchange Commission on 2025-03-20.
Aspira Women's Health Inc. filed a Form D notice of an exempt securities offering with the SEC on March 20, 2025. Aspira Women's Health Inc. trades on OTC as AWHL; it was formerly Vermillion, Inc. The filing reports $1.37M sold. Its industry group is Biotechnology. It names MICHAEL BUHLE (Chief Executive Officer), JAMES CRAWFORD (VP of Finance), JANNIE HERCHUK (Director) (SEC Form D, March 20, 2025).
Is this your company?
Sell to companies like Aspira Women's Health Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-03-20 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Aspira Women's Health Inc.
Free to see. No signup.
More on the people and the money behind Aspira Women's Health Inc., from the filings we hold.
Biotechnology raises by companies based in Texas, filed within 90 days of this one, largest first.
Get an email when Aspira Women's Health Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Aspira Women's Health Inc. raises, hires or launches. No email unless you switch it on.
Watch Aspira Women's Health Inc. →Get the full cited report on Aspira Women's Health Inc.
What the filing shows about Aspira Women's Health Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Aspira Women's Health Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Aspira Women's Health Inc.'s address as 12117 Bee Caves Road, Building III, Suite 100, Austin, TX 78738.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Aspira Women's Health Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Aspira Women's Health Inc. See pricing
Aspira Women's Health Inc. is a registered filer with the SEC (CIK 926617) and has filed since 2024-02-07. 5 filings are on record, the latest on 2026-06-22.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Aspira Women's Health Inc.'s Form D of 2025-03-20 names MICHAEL BUHLE, JAMES CRAWFORD, JANNIE HERCHUK and 6 more as its officers, directors or promoters.
Its new offerings report $14.20M sold across 5 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
On the filing as: Executive Officer.
Michael Buhle is named as Chief Executive Officer on the Form D that Aspira Women's Health Inc. filed with the SEC on 20 March 2025, one of 9 people that filing names.
On the filing as: Executive Officer.
James Crawford is named as Vp of Finance on the Form D that Aspira Women's Health Inc. filed with the SEC on 20 March 2025, one of 9 people that filing names.
Jannie Herchuk is named as Director on the Form D that Aspira Women's Health Inc. filed with the SEC on 20 March 2025, one of 9 people that filing names.
Stefanie Cavanaugh is named as Director on the Form D that Aspira Women's Health Inc. filed with the SEC on 20 March 2025, one of 9 people that filing names.
Celeste Fralick is named as Director on the Form D that Aspira Women's Health Inc. filed with the SEC on 20 March 2025, one of 9 people that filing names.
Ellen O'Connor-Vos is named as Director on the Form D that Aspira Women's Health Inc. filed with the SEC on 20 March 2025, one of 9 people that filing names.
Winfred Parnell is named as Director on the Form D that Aspira Women's Health Inc. filed with the SEC on 20 March 2025, one of 9 people that filing names.
John Ragard is named as Director on the Form D that Aspira Women's Health Inc. filed with the SEC on 20 March 2025, one of 9 people that filing names.
Ellen Beausang is named as Director on the Form D that Aspira Women's Health Inc. filed with the SEC on 20 March 2025, one of 9 people that filing names.
9 people named on the filing — 2 holding an executive role and 7 as directors only.
Named as of the 2025-03-20 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Aspira Women's Health Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Aspira Women's Health Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Aspira Women's Health Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Aspira Women's Health Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Aspira Women's Health Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Aspira Women's Health Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Austin
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/aspira-women-s-health-inc-form-d-25000002